Soley Therapeutics

BiotechnologySeries CSouth San Francisco, USsoleytherapeutics.com

Latest round

Series C

Last raised

Jan 2026

Total raised

$200M

Investors

5

About Soley Therapeutics

Founded in 2020 and headquartered in South San Francisco, USA, Soley Therapeutics focuses on pioneering approaches in drug discovery.Soley Therapeutics specializes in biology-first drug discovery, leveraging human cells as advanced sensors to develop first-in-class medicines. The company's core offerings integrate proprietary imaging, artificial intelligence (AI), and automation technologies to analyze cellular responses to stress and drug exposure, facilitating the rapid translation of cellular data into therapeutic solutions.Soley Therapeutics generates revenue through partnerships and collaborations with pharmaceutical companies and research institutions. The company's business model includes business-to-business (B2B) transactions, providing tailored solutions that leverage its innovative drug discovery platform. The company is also focused on scaling its AI-driven discovery platform to enhance its drug development capabilities. Upcoming efforts include launching new products aimed at addressing unmet medical needs in oncology and expanding its market reach into Europe and Asia by 2027.

Who invested in Soley Therapeutics

5 investors across 1 round

See all investors in Soley Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jan 7, 2026

    Amount

    $200M

    Investors

    Locked

Questions about Soley Therapeutics

Who invested in Soley Therapeutics?

Soley Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Soley Therapeutics raised?

Soley Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Soley Therapeutics last raise money?

Soley Therapeutics's most recent round on record is a Series C, in Jan 2026.

What does Soley Therapeutics do?

Founded in 2020 and headquartered in South San Francisco, USA, Soley Therapeutics focuses on pioneering approaches in drug discovery.

Where is Soley Therapeutics headquartered?

Soley Therapeutics is headquartered in South San Francisco, US.

Which VCs invest in companies like Soley Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Soley Therapeutics's stage. Their profiles are linked below.

Raising like Soley Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.